Skip to main content

This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales).

Rare Diseases

Rare diseases are rare individually but in aggregate they are common; 1 in 17 people have a rare disease¹

Better Care for Rare

Find out about our commitment to faster diagnoses, sustainable access, and integrated patient support in rare diseases

Better Care for Rare

SEE EVERYTHING

Therapeutic areas within Rare Diseases

Get more familiar with the science of rare diseases. Learn about pathophysiology, testing and treatments, including specialised care services

Fabry Disease

SEE EVERYTHING

Pompe Disease

SEE EVERYTHING

MPS I Disease

SEE EVERYTHING

Gaucher Disease

SEE EVERYTHING

Rare Diseases Products

ALDURAZYME
laronidase

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200954 (v2.0)
Date of preparation: February 2023

CERDELGA
eliglustat 84mg

Prescribing Information GB
Prescribing Information NI

MAT-XU-2204064 (v2.0)
Date of preparation: January 2023

Fabrazyme
agalsidase beta

Prescribing Information GB
Prescribing Information NI

MAT-GB-2105812 (v3.0)
Date of preparation: February 2023

CEREZYME
imiglucerase

Prescribing Information GB
Prescribing Information NI

MAT-XU-2204065 (v2.0)
Date of preparation: January 2023

MYOZYME
alglucosidase alfa

Prescribing Information GB
Prescribing Information NI

MAT-GB-2105179 (v3.0)
Date of preparation: February 2023

NEXVIADYME
avalglucosidase alfa

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2203480 (v3.0)
Date of preparation: February 2023

Rare Diseases. National Center for Advancing Translational Sciences. Available at: https://www.raredisease.org.uk/media/1588/the-rare-reality-an-insight-into-the-patient-and-family-experience-of-rare-disease.pdf Accessed August 2022.

MAT-GB-2105722 (v4.0)
Date of preparation: February 2023

YOU ARE NOW LEAVING THE SANOFI CAMPUS UK WEBSITE

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

Continue

Welcome to Sanofi Campus UK

This site is intended for UK healthcare professionals only and contains information on Sanofi UK’s medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs practising in Great Britain (England, Scotland, Wales).

MAT-XU-2300297 (v1.0)
Date of Preparation: February 2023